Swissmedic Announces Archiving of Analgesic Medicinal Product Information Sheets
Published: 2026-02-11 Regulatory teams and medical device professionals should note the upcoming archiving of information sheets on specimen texts for […]
Published: 2026-02-11 Regulatory teams and medical device professionals should note the upcoming archiving of information sheets on specimen texts for […]
As of February 11, 2026, Swissmedic has comprehensively revised the Guidance document Drug Safety Signals HMP, modifying its structure and
As of 1 February 2026, a revised list of variations according to Articles 21-24 of the Swiss Therapeutic Products Ordinance
Meta Description: Swissmedic reports significant non-conformities in wrinkle treatment using medical devices. Published: 2026-02-11 Swissmedic’s recent focus campaign on therapeutic
Temporary authorization for distribution in German packaging A recent announcement by Swissmedic highlights a significant development in the distribution of
As of February 11, 2026, Swissmedic announced a recall of Similasan Schlafstörungen Globuli due to quality issues affecting the product’s
The Jarisch-Herxheimer Reaction An adverse reaction to antibiotic treatment for spirochaetal infections, the Jarisch-Herxheimer reaction is a phenomenon clinicians should
On February 11, 2026, Swissmedic announced the extension of the therapeutic indication for Fabhalta, a medical device used in various
Swissmedic has issued a batch recall notice for Benocten Tropfen zum Einnehmen Lösung, a product used in healthcare settings. The
Swissmedic, the Swiss Agency for Therapeutic Products, has announced the availability of the “Legacy devices” registration system. As of February